Welcome to our dedicated page for Hedgeye 130/30 Equity ETF news (Ticker: HELS), a resource for investors and traders seeking the latest updates and insights on Hedgeye 130/30 Equity ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Hedgeye 130/30 Equity ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Hedgeye 130/30 Equity ETF's position in the market.
Hedgeye Asset Management (HELS) launched the Hedgeye 130/30 Equity ETF on December 12, 2025. The actively managed ETF uses a disciplined 130% gross long / 30% short active extension strategy with roughly 100% net market exposure to pursue long-term capital appreciation.
HELS combines Hedgeye's macro research, quantitative Signals framework and security-specific research, reinvesting short proceeds into high-conviction longs. The fund is managed by R. Patrick Kent, who has more than 25 years of investment experience.
FAQ
What is the current stock price of Hedgeye 130/30 Equity ETF (HELS)?
